ConductScience.org, home

Paper8375129

The influence of dose and ethnic origins on the pharmacokinetics of nifedipine.

Ahsan CH and 5 others. Clin Pharmacol Ther, 1993. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. The influence of dose and ethnic origins on the pharmacokinetics of nifedipine. Papers, record 8375129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8375129

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The influence of dose and ethnic origins on the pharmacokinetics of nifedipine.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2022-12-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahsan CHC H
2Renwick AGA G
3Waller DGD G
4Challenor VFV F
5George CFC F
6Amanullah MM

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NifedipineMajor topic
White PeopleMajor topic
Adult
Bangladesh
Blood Proteins
Female
Half-Life
Hemodynamics
Humans
Male
Middle Aged
Protein Binding
Reference Values

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42296571Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions.Pharmacol Rev2026https://conductscience.org/library/papers/42296571PubMed
41499374Using Physiologically Based Pharmacokinetic Modeling and Simulations to Predict Antihypertensive Drug Doses in Cirrhotic Patients.J Clin Pharmacol2026https://conductscience.org/library/papers/41499374PubMed
38130031Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/38130031PubMed
37309079Model-based meta-analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism.CPT Pharmacometrics Syst Pharmacol2023https://conductscience.org/library/papers/37309079PubMed
34273255Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome.CPT Pharmacometrics Syst Pharmacol2021https://conductscience.org/library/papers/34273255PubMed
30629861Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.Clin Pharmacol Drug Dev2019https://conductscience.org/library/papers/30629861PubMed
30386625Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects.Pharmacol Res Perspect2018https://conductscience.org/library/papers/30386625PubMed
25385446Interethnic differences in pharmacokinetics of antibacterials.Clin Pharmacokinet2015https://conductscience.org/library/papers/25385446PubMed
24869931
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.
Oncologist2014https://conductscience.org/library/papers/24869931PubMed
16984210Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.Clin Pharmacokinet2006https://conductscience.org/library/papers/16984210PubMed
14531721Dietary effects on drug metabolism and transport.Clin Pharmacokinet2003https://conductscience.org/library/papers/14531721PubMed
11422016Population pharmacokinetics of carbamazepine in Singapore epileptic patients.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11422016PubMed
10319190Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.Cell Mol Neurobiol1999https://conductscience.org/library/papers/10319190PubMed
9663814Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9663814PubMed
9342505Clinical pharmacokinetic considerations in the elderly. An update.Clin Pharmacokinet1997https://conductscience.org/library/papers/9342505PubMed
9084960Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.Clin Pharmacokinet1997https://conductscience.org/library/papers/9084960PubMed
9084065The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons.Psychopharmacology (Berl)1997https://conductscience.org/library/papers/9084065PubMed
8703655Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8703655PubMed
8527268Factors affecting the absolute bioavailability of nifedipine.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527268PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8375129

GET https://conductscience.org/api/papers/v1/8375129/authors